Clinical Trial

INFINITY™ With ADAPTIS™ Technology Study

Study acronym: ITAR2
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
INFINITY™ with ADAPTIS™ Technology Total Ankle Replacement Follow-up (ITAR2) - Prospective, multi-site, multi-year post-market clinical follow-up study Study Group Primary/Unilateral and/or bilateral Total Ankle Arthroplasty subjects implanted with INFINITY™ Total Ankle System Number of Subjects 200 patients with up to 13 sites
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2020-10-17; most recent amendment 2026-03-20.
Status change: Recruiting → Active, Not Recruiting 2024-11-01
Status change: Active, Not Recruiting → Recruiting 2024-02-16
Status change: Recruiting → Active, Not Recruiting 2023-10-06
Status change: Not Yet Recruiting → Recruiting 2021-04-05
Trial Details
NCT Number NCT04594993
Lead Sponsor Stryker Trauma and Extremities
Conditions Arthritis, Rheumatoid
Enrollment 200 participants
Start Date 2021-02-09
Primary Completion 2033-11 (estimated)
Study Completion 2035-11 (estimated)
Updated on ClinicalTrials.gov 2026-03-25